Insulet Corporation's ability to collect accounts receivable sequentially worsen to 6.24, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Insulet's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 58 days, from 53 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 128 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 454 to 1172.

What is Receivable Turnover Ratio?
What is Insulet Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PODD Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	92.13 %	92.41 %	104.71 %	17.12 %	23.05 %
Y / Y Revenue Change	23.51 %	33.87 %	31.16 %	29.86 %	32.88 %
Receivable Turnover Ratio (TTM)	6.24	6.93	7.67	8.78	8.55
PODD's Total Ranking	# 1172	# 454	# 813	# 1307	#
Accounts Receivable average collection period days	58	53	48	42	43
Seq. Receivable Change	8.08 %	5.38 %	68.65 %	0.03 %	8.23 %
Seq. Revenue Change	5.25 %	-2.81 %	10.96 %	8.81 %	14.08 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 41
Healthcare Sector	# 129
Overall Market	# 1172

Receivable Turnover Ratio Statistics
High	Average	Low
11.32	7.73	-4.49
(Sep 30 2017)		(Dec 31 2018)

News about Insulet Corporation Receivables Turnover Ratios

Insulet Expands Reach with Launch of Omnipod 5 in Europe Amid Financial Challenges

In a significant advancement for diabetes management, Insulet Corporation, a pioneer in tubeless insulin pump technology headquartered in Acton, Massachusetts, has announced the commercial launch of its revolutionary Omnipod 5 Automated Insulin Delivery System in five additional countries across Europe: Italy, Denmark, Finland, Norway, and Sweden. This move marks another step in Insulet s mission to provide innovative diabetes care solutions to patients globally.The Omnipod 5 system, designed to simplify insulin delivery, enhances patient convenience and lifestyle integration. Notably, the new system is compatible with both Abbott s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring (CGM) sensors, allowing users to maintain more precise control over their blood glucose levels. This compatibility is expected to facilitate better management of diabetes for users in the newly added European markets, thereby improving their quality of life.

PODD Company Profile • Back to PODD Efficiency Comparisons • Compare PODD Receivables Turnover Ratio to its Competitors

Financial Statements
Insulet's Accounts Receivable	$ 589 Millions	Visit PODD's Balance sheet
Insulet's Sales TTM	$ 3,053 Millions	Visit PODD's Income Statement
Sources of PODD's Revenues		Visit PODD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PODD's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PODD's Growth Rates	PODD's Roa	PODD's Inventory Turnover Ratio	PODD's Dividend Comparisons
PODD's Profitability Ratios	PODD's Roi	PODD's Asset Turnover Ratio	PODD's Dividend Growth
PODD's Valuation Ratios	PODD's Roe	PODD's Financial Strength Ratios	PODD's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Lftd Partners Inc	14.13	$ 35.335 Millions	$ 2.500 Millions
Talkspace Inc	14.09	$ 246.631 Millions	$ 17.506 Millions
Lifestance Health Group Inc	14.07	$ 1,584.834 Millions	$ 112.665 Millions
Ataibeckley Inc	13.83	$ 4.473 Millions	$ 0.324 Millions
Amneal Pharmaceuticals Inc	13.83	$ 3,117.474 Millions	$ 225.492 Millions
Arvinas Inc	13.49	$ 316.700 Millions	$ 23.475 Millions
Rosecliff Acquisition Corp I	13.43	$ 16.467 Millions	$ 1.226 Millions
Corcept Therapeutics Inc	13.30	$ 830.813 Millions	$ 62.477 Millions
Precipio inc	13.25	$ 27.198 Millions	$ 2.052 Millions
Skinhealth Systems Inc	13.04	$ 289.224 Millions	$ 22.179 Millions
Chemed Corporation	12.94	$ 2,595.001 Millions	$ 200.565 Millions
Qhslab Inc	12.77	$ 3.017 Millions	$ 0.236 Millions
Petvivo Holdings Inc	12.34	$ 1.182 Millions	$ 0.096 Millions
Siga Technologies Inc	12.32	$ 53.659 Millions	$ 4.356 Millions
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions
Milestone Scientific Inc	11.82	$ 8.855 Millions	$ 0.749 Millions
Marpai Inc	11.71	$ 16.635 Millions	$ 1.420 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Icu Medical Inc	11.42	$ 2,159.998 Millions	$ 189.166 Millions
National Healthcare Corp	11.40	$ 1,559.020 Millions	$ 136.723 Millions
Nrc Health	11.35	$ 139.996 Millions	$ 12.337 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Premier Air Charter Holdings Inc	10.66	$ 31.562 Millions	$ 2.961 Millions
C4 Therapeutics Inc	10.65	$ 35.039 Millions	$ 3.290 Millions
Lifeloc Technologies Inc	10.48	$ 9.269 Millions	$ 0.884 Millions
Irhythm Holdings Inc	10.32	$ 825.702 Millions	$ 80.007 Millions
Immucell Corporation	10.29	$ 29.777 Millions	$ 2.893 Millions

Date modified: 2026-09-10T06:09:54+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.